IL1B and gastric cancer: This is consistent with the results of previous studies that added GLP that 400 mg/kg GLP reduced serum levels of IL-1β and IL-6 in diabetic rats [15], and 800 mg/kg GLP reduced serum IL-6 and TNF-α levels and increased serum IL-2, IL-4, and IL-10 levels in rats with gastric cancer [33].